 | • レポートコード：B-GIR08C4010 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ニネタニブの世界市場について調べ、まとめました。種類別セグメントは、100mg * 10カプセル、150mg * 10カプセル、100mg * 30カプセル、150mg * 30カプセル、150mg * 60カプセル等、用途別セグメントは、ローカルアドバンスドNSCLC、バリアントNSCLC、ローカルリカレントNSCLC等に区分しました。ニネタニブの世界市場概観、企業動向、企業別ニネタニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ニネタニブの市場概観 ・ニネタニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ニネタニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ニネタニブの世界市場規模 ・ニネタニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ニネタニブのアメリカ市場規模推移 ・ニネタニブのカナダ市場規模推移 ・ニネタニブのメキシコ市場規模推移 ・ニネタニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ニネタニブのドイツ市場規模推移 ・ニネタニブのイギリス市場規模推移 ・ニネタニブのロシア市場規模推移 ・ニネタニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ニネタニブの日本市場規模推移 ・ニネタニブの中国市場規模推移 ・ニネタニブの韓国市場規模推移 ・ニネタニブのインド市場規模推移 ・ニネタニブの東南アジア市場規模推移 ・ニネタニブの南米市場分析（ブラジル、アルゼンチン等） ・ニネタニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ニネタニブの種類別分析/販売量、売上、市場シェア（100mg * 10カプセル、150mg * 10カプセル、100mg * 30カプセル、150mg * 30カプセル、150mg * 60カプセル） ・ニネタニブの用途別分析/市場規模（ローカルアドバンスドNSCLC、バリアントNSCLC、ローカルリカレントNSCLC） ・ニネタニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ニネタニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Nintedanib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nintedanib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boehringer Ingelheim Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100mg*10 Capsules
150mg*10 Capsules
100mg*30 Capsules
150mg*30 Capsules
150mg*60 Capsules
Market Segment by Applications, can be divided into
Locally Advanced NSCLC
Variant NSCLC
Locally Recurrent NSCLC
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nintedanib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nintedanib, with price, sales, revenue and global market share of Nintedanib in 2017 and 2018.
Chapter 3, the Nintedanib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nintedanib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nintedanib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nintedanib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nintedanib Introduction
1.2 Market Analysis by Type
1.2.1 100mg*10 Capsules
1.2.2 150mg*10 Capsules
1.2.3 100mg*30 Capsules
1.2.4 150mg*30 Capsules
1.2.5 150mg*60 Capsules
1.3 Market Analysis by Applications
1.3.1 Locally Advanced NSCLC
1.3.2 Variant NSCLC
1.3.3 Locally Recurrent NSCLC
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim Pharma
2.1.1 Business Overview
2.1.2 Nintedanib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim Pharma Nintedanib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nintedanib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Nintedanib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Nintedanib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Nintedanib Manufacturer Market Share in 2018
3.3.2 Top 6 Nintedanib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Nintedanib Market Analysis by Regions
4.1 Global Nintedanib Sales, Revenue and Market Share by Regions
4.1.1 Global Nintedanib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Nintedanib Revenue and Market Share by Regions (2014-2019)
4.2 North America Nintedanib Sales and Growth Rate (2014-2019)
4.3 Europe Nintedanib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Nintedanib Sales and Growth Rate (2014-2019)
4.5 South America Nintedanib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Nintedanib Sales and Growth Rate (2014-2019)
5 North America Nintedanib by Country
5.1 North America Nintedanib Sales, Revenue and Market Share by Country
5.1.1 North America Nintedanib Sales and Market Share by Country (2014-2019)
5.1.2 North America Nintedanib Revenue and Market Share by Country (2014-2019)
5.2 United States Nintedanib Sales and Growth Rate (2014-2019)
5.3 Canada Nintedanib Sales and Growth Rate (2014-2019)
5.4 Mexico Nintedanib Sales and Growth Rate (2014-2019)
6 Europe Nintedanib by Country
6.1 Europe Nintedanib Sales, Revenue and Market Share by Country
6.1.1 Europe Nintedanib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Nintedanib Revenue and Market Share by Country (2014-2019)
6.2 Germany Nintedanib Sales and Growth Rate (2014-2019)
6.3 UK Nintedanib Sales and Growth Rate (2014-2019)
6.4 France Nintedanib Sales and Growth Rate (2014-2019)
6.5 Russia Nintedanib Sales and Growth Rate (2014-2019)
6.6 Italy Nintedanib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Nintedanib by Country
7.1 Asia-Pacific Nintedanib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Nintedanib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Nintedanib Revenue and Market Share by Country (2014-2019)
7.2 China Nintedanib Sales and Growth Rate (2014-2019)
7.3 Japan Nintedanib Sales and Growth Rate (2014-2019)
7.4 Korea Nintedanib Sales and Growth Rate (2014-2019)
7.5 India Nintedanib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Nintedanib Sales and Growth Rate (2014-2019)
8 South America Nintedanib by Country
8.1 South America Nintedanib Sales, Revenue and Market Share by Country
8.1.1 South America Nintedanib Sales and Market Share by Country (2014-2019)
8.1.2 South America Nintedanib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Nintedanib Sales and Growth Rate (2014-2019)
8.3 Argentina Nintedanib Sales and Growth Rate (2014-2019)
8.4 Colombia Nintedanib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Nintedanib by Countries
9.1 Middle East and Africa Nintedanib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Nintedanib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Nintedanib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Nintedanib Sales and Growth Rate (2014-2019)
9.3 Turkey Nintedanib Sales and Growth Rate (2014-2019)
9.4 Egypt Nintedanib Sales and Growth Rate (2014-2019)
9.5 Nigeria Nintedanib Sales and Growth Rate (2014-2019)
9.6 South Africa Nintedanib Sales and Growth Rate (2014-2019)
10 Global Nintedanib Market Segment by Type
10.1 Global Nintedanib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Nintedanib Sales and Market Share by Type (2014-2019)
10.1.2 Global Nintedanib Revenue and Market Share by Type (2014-2019)
10.2 100mg*10 Capsules Sales Growth and Price
10.2.1 Global 100mg*10 Capsules Sales Growth (2014-2019)
10.2.2 Global 100mg*10 Capsules Price (2014-2019)
10.3 150mg*10 Capsules Sales Growth and Price
10.3.1 Global 150mg*10 Capsules Sales Growth (2014-2019)
10.3.2 Global 150mg*10 Capsules Price (2014-2019)
10.4 100mg*30 Capsules Sales Growth and Price
10.4.1 Global 100mg*30 Capsules Sales Growth (2014-2019)
10.4.2 Global 100mg*30 Capsules Price (2014-2019)
10.5 150mg*30 Capsules Sales Growth and Price
10.5.1 Global 150mg*30 Capsules Sales Growth (2014-2019)
10.5.2 Global 150mg*30 Capsules Price (2014-2019)
10.6 150mg*60 Capsules Sales Growth and Price
10.6.1 Global 150mg*60 Capsules Sales Growth (2014-2019)
10.6.2 Global 150mg*60 Capsules Price (2014-2019)
11 Global Nintedanib Market Segment by Application
11.1 Global Nintedanib Sales Market Share by Application (2014-2019)
11.2 Locally Advanced NSCLC Sales Growth (2014-2019)
11.3 Variant NSCLC Sales Growth (2014-2019)
11.4 Locally Recurrent NSCLC Sales Growth (2014-2019)
12 Nintedanib Market Forecast (2019-2024)
12.1 Global Nintedanib Sales, Revenue and Growth Rate (2019-2024)
12.2 Nintedanib Market Forecast by Regions (2019-2024)
12.2.1 North America Nintedanib Market Forecast (2019-2024)
12.2.2 Europe Nintedanib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Nintedanib Market Forecast (2019-2024)
12.2.4 South America Nintedanib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Nintedanib Market Forecast (2019-2024)
12.3 Nintedanib Market Forecast by Type (2019-2024)
12.3.1 Global Nintedanib Sales Forecast by Type (2019-2024)
12.3.2 Global Nintedanib Market Share Forecast by Type (2019-2024)
12.4 Nintedanib Market Forecast by Application (2019-2024)
12.4.1 Global Nintedanib Sales Forecast by Application (2019-2024)
12.4.2 Global Nintedanib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Nintedanib Picture
Table Product Specifications of Nintedanib
Figure Global Sales Market Share of Nintedanib by Types in 2018
Table Nintedanib Types for Major Manufacturers
Figure 100mg*10 Capsules Picture
Figure 150mg*10 Capsules Picture
Figure 100mg*30 Capsules Picture
Figure 150mg*30 Capsules Picture
Figure 150mg*60 Capsules Picture
Figure Nintedanib Sales Market Share by Applications in 2018
Figure Locally Advanced NSCLC Picture
Figure Variant NSCLC Picture
Figure Locally Recurrent NSCLC Picture
Figure United States Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure France Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure China Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure India Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Nintedanib Revenue (Value) and Growth Rate (2014-2024)
Table Boehringer Ingelheim Pharma Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Pharma Nintedanib Type and Applications
Table Boehringer Ingelheim Pharma Nintedanib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nintedanib Sales by Manufacturer (2017-2018)
Figure Global Nintedanib Sales Market Share by Manufacturer in 2017
Figure Global Nintedanib Sales Market Share by Manufacturer in 2018
Table Global Nintedanib Revenue by Manufacturer (2017-2018)
Figure Global Nintedanib Revenue Market Share by Manufacturer in 2017
Figure Global Nintedanib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Nintedanib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Nintedanib Manufacturer (Revenue) Market Share in 2018
Figure Global Nintedanib Sales and Growth Rate (2014-2019)
Figure Global Nintedanib Revenue and Growth Rate (2014-2019)
Table Global Nintedanib Sales by Regions (2014-2019)
Table Global Nintedanib Sales Market Share by Regions (2014-2019)
Table Global Nintedanib Revenue by Regions (2014-2019)
Figure Global Nintedanib Revenue Market Share by Regions (2014-2019)
Figure Global Nintedanib Revenue Market Share by Regions in 2018
Figure North America Nintedanib Sales and Growth Rate (2014-2019)
Figure Europe Nintedanib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nintedanib Sales and Growth Rate (2014-2019)
Figure South America Nintedanib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nintedanib Sales and Growth Rate (2014-2019)
Figure North America Nintedanib Revenue and Growth Rate (2014-2019)
Table North America Nintedanib Sales by Countries (2014-2019)
Table North America Nintedanib Sales Market Share by Countries (2014-2019)
Figure North America Nintedanib Sales Market Share by Countries (2014-2019)
Figure North America Nintedanib Sales Market Share by Countries in 2018
Table North America Nintedanib Revenue by Countries (2014-2019)
Table North America Nintedanib Revenue Market Share by Countries (2014-2019)
Figure North America Nintedanib Revenue Market Share by Countries (2014-2019)
Figure North America Nintedanib Revenue Market Share by Countries in 2018
Figure United States Nintedanib Sales and Growth Rate (2014-2019)
Figure Canada Nintedanib Sales and Growth Rate (2014-2019)
Figure Mexico Nintedanib Sales and Growth Rate (2014-2019)
Figure Europe Nintedanib Revenue and Growth Rate (2014-2019)
Table Europe Nintedanib Sales by Countries (2014-2019)
Table Europe Nintedanib Sales Market Share by Countries (2014-2019)
Table Europe Nintedanib Revenue by Countries (2014-2019)
Figure Europe Nintedanib Revenue Market Share by Countries (2014-2019)
Figure Europe Nintedanib Revenue Market Share by Countries in 2018
Figure Germany Nintedanib Sales and Growth Rate (2014-2019)
Figure UK Nintedanib Sales and Growth Rate (2014-2019)
Figure France Nintedanib Sales and Growth Rate (2014-2019)
Figure Russia Nintedanib Sales and Growth Rate (2014-2019)
Figure Italy Nintedanib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nintedanib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nintedanib Sales by Countries (2014-2019)
Table Asia-Pacific Nintedanib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Nintedanib Sales Market Share by Countries 2018
Table Asia-Pacific Nintedanib Revenue by Countries (2014-2019)
Figure Asia-Pacific Nintedanib Revenue Market Share by Countries 2018
Figure China Nintedanib Sales and Growth Rate (2014-2019)
Figure Japan Nintedanib Sales and Growth Rate (2014-2019)
Figure Korea Nintedanib Sales and Growth Rate (2014-2019)
Figure India Nintedanib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Nintedanib Sales and Growth Rate (2014-2019)
Figure South America Nintedanib Revenue and Growth Rate (2014-2019)
Table South America Nintedanib Sales by Countries (2014-2019)
Table South America Nintedanib Sales Market Share by Countries (2014-2019)
Figure South America Nintedanib Sales Market Share by Countries in 2018
Table South America Nintedanib Revenue by Countries (2014-2019)
Table South America Nintedanib Revenue Market Share by Countries (2014-2019)
Figure South America Nintedanib Revenue Market Share by Countries in 2018
Figure Brazil Nintedanib Sales and Growth Rate (2014-2019)
Figure Argentina Nintedanib Sales and Growth Rate (2014-2019)
Figure Colombia Nintedanib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nintedanib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nintedanib Sales by Countries (2014-2019)
Table Middle East and Africa Nintedanib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Nintedanib Sales Market Share by Countries in 2018
Table Middle East and Africa Nintedanib Revenue by Countries (2014-2019)
Table Middle East and Africa Nintedanib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nintedanib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nintedanib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nintedanib Sales and Growth Rate (2014-2019)
Figure UAE Nintedanib Sales and Growth Rate (2014-2019)
Figure Egypt Nintedanib Sales and Growth Rate (2014-2019)
Figure Nigeria Nintedanib Sales and Growth Rate (2014-2019)
Figure South Africa Nintedanib Sales and Growth Rate (2014-2019)
Table Global Nintedanib Sales by Type (2014-2019)
Table Global Nintedanib Sales Share by Type (2014-2019)
Table Global Nintedanib Revenue by Type (2014-2019)
Table Global Nintedanib Revenue Share by Type (2014-2019)
Figure Global 100mg*10 Capsules Sales Growth (2014-2019)
Figure Global 100mg*10 Capsules Price (2014-2019)
Figure Global 150mg*10 Capsules Sales Growth (2014-2019)
Figure Global 150mg*10 Capsules Price (2014-2019)
Figure Global 100mg*30 Capsules Sales Growth (2014-2019)
Figure Global 100mg*30 Capsules Price (2014-2019)
Figure Global 150mg*30 Capsules Sales Growth (2014-2019)
Figure Global 150mg*30 Capsules Price (2014-2019)
Figure Global 150mg*60 Capsules Sales Growth (2014-2019)
Figure Global 150mg*60 Capsules Price (2014-2019)
Table Global Nintedanib Sales by Application (2014-2019)
Table Global Nintedanib Sales Share by Application (2014-2019)
Figure Global Variant NSCLC Sales Growth (2014-2019)
Figure Global Locally Recurrent NSCLC Sales Growth (2014-2019)
Figure Global Nintedanib Sales, Revenue and Growth Rate (2019-2024)
Table Global Nintedanib Sales Forecast by Regions (2019-2024)
Table Global Nintedanib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Nintedanib Market Forecast (2019-2024)
Figure Europe Sales Nintedanib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Nintedanib Market Forecast (2019-2024)
Figure South America Sales Nintedanib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Nintedanib Market Forecast (2019-2024)
Table Global Nintedanib Sales Forecast by Type (2019-2024)
Table Global Nintedanib Market Share Forecast by Type (2019-2024)
Table Global Nintedanib Sales Forecast by Application (2019-2024)
Table Global Nintedanib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
蒸気カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Vapor Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vapor Capsules in global…- HPMCカプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow produ…
- 世界の内視鏡用カプセル市場2019 The global Endoscopy Capsules market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Endoscopy Capsules market status and forecast, categorizes the global Endoscopy Capsules market size (value & vo…
- ベジタリアン系カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Vegetarian Based Capsules is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vegetarian Based Capsul…
- クリゾチニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Crizotinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Crizotinib in global market,…